Polyrizon Completes All Five U.S. Site Contracts for NASARIX™ First-in-Human Allergy Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/19/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. RTB
6. ONON
7. AAPL
8. TRMD
9. ACN
10. AZN

Go back to Polyrizon Completes All Five U.S. Site Contracts for NASARIX™ First-in-Human Allergy Study
(NASDAQ: PLRZ) Delayed: 10.99 -0.04 (0.36%)
Previous Close $11.03    52 Week High $ 
Open $11.01    52 Week Low $ 
Day High $11.07    P/E N/A 
Day Low $10.36    EPS $ 
Volume 32,056